SCM
Stonepine Capital Management Portfolio holdings
AUM
$123M
1-Year Est. Return
43.21%
1 Year Est. Return
+43.21%
AUM
$123M
AUM Growth
+$21.5M
(+21%)
Holding
77
Top Buys
| 1 | +$11.6M | |
| 2 | +$3.81M | |
| 3 | +$3.61M | |
| 4 |
OmniAb
OABI
|
+$3.43M |
| 5 |
Abeona Therapeutics
ABEO
|
+$2.14M |
Top Sells
| 1 | +$6.03M | |
| 2 | +$3.58M | |
| 3 | +$3.09M | |
| 4 |
ANI Pharmaceuticals
ANIP
|
+$2.52M |
| 5 |
Anika Therapeutics
ANIK
|
+$2.02M |
Sector Composition
| 1 | Healthcare | 99.76% |
| 2 | Financials | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Verastem
VSTM
$779M
| $23.6M | 19.17% |
2,670,032
+1,309,646
|
|
||
2
ADMA Biologics
ADMA
$4.61B
| $10.8M | 8.81% |
739,000
-11,000
|
|
||
3
Evolus
EOLS
$442M
| $9.43M | 7.67% |
1,536,391
+619,891
|
|
||
4
Zevra Therapeutics
ZVRA
$470M
| $7.7M | 6.26% |
810,000
+34,380
|
|
||
5
Nektar Therapeutics
NKTR
$1.24B
| $4.84M | 3.93% |
85,000
+34,800
|
|
||
6
Day One Biopharmaceuticals
DAWN
$901M
| $4.56M | 3.71% |
647,382
+197,382
|
|
||
7
Xoma
XOMA
$385M
| $4.45M | 3.62% |
115,459
-36,684
|
|
||
8
Acadia Pharmaceuticals
ACAD
$4.2B
| $3.72M | 3.03% |
174,544
-50,456
|
|
||
9
Enanta Pharmaceuticals
ENTA
$408M
| $3.65M | 2.97% |
305,000
-299,066
|
|
||
10
X4 Pharmaceuticals
XFOR
$275M
| $3.61M | 2.94% |
+1,056,338
|
|
||
|
11
OmniAb
OABI
$250M
| $3.43M | 2.79% |
+2,142,857
|
|
||
12
Surrozen
SRZN
$138M
| $3.22M | 2.62% |
250,146
-55,883
|
|
||
13
TELA Bio
TELA
$50.3M
| $3.21M | 2.61% |
2,155,519
+71,757
|
|
||
14
Indivior
INDV
$4.2B
| $2.41M | 1.96% |
100,000
-250,000
|
|
||
|
15
Abeona Therapeutics
ABEO
$259M
| $2.38M | 1.94% |
450,970
+405,970
|
|
||
16
Geron
GERN
$760M
| $2.19M | 1.78% |
1,600,000
+600,000
|
|
||
17
PMV Pharmaceuticals
PMVP
$68.6M
| $1.92M | 1.56% |
1,370,139
+524,171
|
|
||
18
Edesa Biotech
EDSA
$12.6M
| $1.7M | 1.38% |
+687,500
|
|
||
19
AYTU BioPharma
AYTU
$21M
| $1.68M | 1.36% |
891,855
+79,179
|
|
||
20
Soleno Therapeutics
SLNO
$2.63B
| $1.62M | 1.32% |
+24,000
|
|
||
21
Kezar Life Sciences
KZR
$45.6M
| $1.49M | 1.21% |
383,182
+213,323
|
|
||
|
ALMS
22
Alumis Inc
ALMS
$767M
| $1.2M | 0.97% |
300,000
-49,615
|
|
||
23
Inhibikase Therapeutics
IKT
$182M
| $1.19M | 0.97% |
735,019
+1,226
|
|
||
|
BIOA
24
BioAge Labs
BIOA
$320M
| $1.11M | 0.9% |
188,571
+37,486
|
|
||
25
Ardelyx
ARDX
$1.36B
| $1.1M | 0.9% |
200,000
-355,000
|
|